MA42553A - Formulations à libération prolongée de flurbiprofène et de tramadol - Google Patents
Formulations à libération prolongée de flurbiprofène et de tramadolInfo
- Publication number
- MA42553A MA42553A MA042553A MA42553A MA42553A MA 42553 A MA42553 A MA 42553A MA 042553 A MA042553 A MA 042553A MA 42553 A MA42553 A MA 42553A MA 42553 A MA42553 A MA 42553A
- Authority
- MA
- Morocco
- Prior art keywords
- tramadol
- flurbiprofen
- sustained
- release formulations
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR201605504 | 2016-04-28 | ||
| TR2016/05632A TR201605632A1 (tr) | 2016-04-28 | 2016-05-02 | Flurbi̇profen ve tramadolün yavaş salinimli kombi̇nasyonlari |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42553A true MA42553A (fr) | 2018-06-06 |
Family
ID=58638778
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042552A MA42552A (fr) | 2016-04-28 | 2017-04-27 | Compositions pharmaceutiques de flurbiprofène et de tramadol |
| MA042553A MA42553A (fr) | 2016-04-28 | 2017-04-27 | Formulations à libération prolongée de flurbiprofène et de tramadol |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042552A MA42552A (fr) | 2016-04-28 | 2017-04-27 | Compositions pharmaceutiques de flurbiprofène et de tramadol |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20170312236A1 (fr) |
| EP (1) | EP3238713A1 (fr) |
| MA (2) | MA42552A (fr) |
| TR (1) | TR201605632A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11554112B2 (en) | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| TWI908716B (zh) * | 2019-02-13 | 2025-12-21 | 愛爾蘭商伊泰倫醫療國際有限公司 | β-內醯胺化合物及丙磺舒之組合及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6339105B1 (en) | 1999-10-12 | 2002-01-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analgesic regimen |
| US20080031950A1 (en) * | 2007-04-27 | 2008-02-07 | Nectid Inc. | Novel anelgesic combination |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
-
2016
- 2016-05-02 TR TR2016/05632A patent/TR201605632A1/tr unknown
-
2017
- 2017-04-26 US US15/498,100 patent/US20170312236A1/en not_active Abandoned
- 2017-04-27 MA MA042552A patent/MA42552A/fr unknown
- 2017-04-27 EP EP17168457.4A patent/EP3238713A1/fr not_active Withdrawn
- 2017-04-27 MA MA042553A patent/MA42553A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20170312236A1 (en) | 2017-11-02 |
| TR201605632A1 (tr) | 2017-11-21 |
| MA42552A (fr) | 2018-06-06 |
| EP3238713A1 (fr) | 2017-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3523390T (pt) | Utilização de composições à base de tetrafluoropropeno | |
| EP3453938A4 (fr) | Mécanisme de bouton de trépied et trépied | |
| MA44725A (fr) | Formulations d'un inhibiteur de lsd1 | |
| EP3509581A4 (fr) | Formulations de (r | |
| EP3298353A4 (fr) | Réponses à des questions d'image multilingue | |
| PT3548033T (pt) | Compostos e respectivos métodos de utilização | |
| EP3478215A4 (fr) | Appareil orthodontique à autoligature | |
| HUE052468T2 (hu) | Arginázgátlók és terápiás alkalmazásaik | |
| EP3332358A4 (fr) | Imagerie à super-résolution d'interactions protéine-protéine | |
| EP3250367A4 (fr) | Étalonnage d'agent | |
| EP3465453A4 (fr) | Interface à nombre de broches réduit | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| MA44212A (fr) | Prégabaline à libération prolongée contrôlée | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| EP3425215A4 (fr) | Structure à sillons et objet | |
| EP3347334A4 (fr) | Déshydrohalogénation d'hydrochlorofluorocarbones | |
| EP3658683A4 (fr) | Découverte d'épitopes à médiation par trogocytose | |
| IL281976A (en) | Anti-fgfr2 antibody formulations | |
| EP3467365A4 (fr) | Appareil à thermostat | |
| EP3512521A4 (fr) | Composition pharmaceutique de clozapine à libération prolongée | |
| DK3678644T3 (da) | Formuleringer af copanlisib | |
| EP3323363A4 (fr) | Ensemble ancrage à vis | |
| DK3512518T3 (da) | Buprenophinformuleringer med langvarig frigivelse | |
| EP3955910A4 (fr) | Formulations à libération prolongée | |
| EP3471740A4 (fr) | Compositions et méthodes d'utilisation de nanomédicaments à base d'albumine |